Either you’re preaching to the converted or I think you missed...

Either you’re preaching to the converted or I think you missed the parts of my post whereby I clearly state that Biotron have the potential to be part of the solution, but there’s no way they’ll do that alone. If one of their compounds prove successful, it’ll form part of an adjunctive therapy, not a stand alone “pill”. The scale required for said pill to be offered to the wider community would not be produced by Biotron as they don’t have the facilities for mass scale. Gilead was an an analogy BTW. As with their proposed Phase II(b) or Phase III clinical trials, Biotron won’t do it alone, they’ll seek assistance by way of partnerships for any potential compound solution.

Enough said.